ChM sp. z o.o. — over 40 years of experience combining engineering, medicine, and research to create comprehensive implant and instrument systems for trauma, spine, and craniofacial surgery. Our products ensure treatment effectiveness and surgical comfort. We develop intramedullary nails, locking plates, and niche implants like KPS or FN. With CHARSPINE2 and tailor-made solutions, ChM delivers innovation and proven quality confirmed by ISO and CE certificates.
Celon Pharma S.A.
Celon Pharma S.A. is European clinical-stage and commercial biopharmaceutical company founded in 2002 and listed on the Warsaw Stock Exchange (WSE: CLN). We hope to improve the lives of people suffering from neurological, metabolic, anti-inflammatory, and oncological diseases by developing novel therapies using sophisticated technologies such as mRNA and bispecifics. We have built a highly experienced 220-scientist team of seasoned leaders and drug developers who combine a nimble, results-driven mindset with expertise in clinical design and execution as well as drug discovery and development located in the complex state-of-the-art R&D facility. Our clinical and preclinical pipeline includes wholly-owned therapeutic candidates targeting difficult-to-treat cancers, autoimmune diseases, and other serious diseases. With our unique heritage, we are powered to advance our 16 active research and development programs out of which 5 are currently in clinical development. Celon currently implements 16 of innovative research projects in these areas, 5 of which are in the clinical phase. Celon’s most advanced programs are the Falkieri program concerning the use of esketamine in the treatment of drug-resistant depression, bipolar affective disorder, the CPL’36 program concerning the use of the PDE10a inhibitor in the treatment of schizophrenia and psychomotor disorders, the CPL’110 program concerning the use of the FGFR inhibitor in the treatment of solid tumors (bladder, lung, gastric), and the CPL’280 program concerning the use of the GPR40 agonist in the treatment of diabetes and diabetic neuropathy. We develop our innovative programs with respect to the requirements of global Regulatory Authorities. We are resource- and capital-efficient in the development of our therapeutic candidates by revenues from well-developed generics sales and heavily co-financing by European Union non-refundable grants. Discover our innovative pipeline: https://www.youtube.com/watch?v=Imbt3ETDKjk Celon’s research and development model is based on fully integrated in-house capabilities, starting from the development of a drug idea to manufacturing for the purposes of clinical trials. Celon develops innovative projects until Phase II clinical trials with the aim of finding a partner for Phase III and out-licensing the sale of a drug. We would like to present to potential partners our clinical innovative assets, our preclinical programs and mRNA platform. We are also seeking new interested investors.
CBK Technik Group
CBK Technik Group specializes in the production of autoscooters, funhouses, ghosttrains etc. Our recreational equipment is characterized by the highest quality, durability and safety, thanks to which it has gained recognition on the market. Our team of engineers and employees are highly qualified specialists with many years of experience. We have been operating continuously for over 30 years, which allows us to deliver reliable products that meet the expectations of the most demanding customers
Caruma
Caruma provides a blockchain-based Digital Product Passport (DPP) platform that enables EU ESPR compliance, end-to-end traceability, and a circular economy through secure, verifiable data and QR/NFC technology. We also deliver enterprise blockchain solutions: tokenization, NFT ticketing, and AI-driven IoT-to-blockchain integration.
Brighter Lighting
Brighter Lighting is a Polish brand of professional stage lighting created in response to genuine market demand. We combine engineering precision, experience, and modern technologies to provide reliable, high-performance fixtures with a solid construction and stable operation. Our solutions are designed for professionals who expect visual effects, easy integration and a long product lifespan. Having grown from experience in the Polish market, the brand is now dynamically developing its international presence. This year, Brighter Lighting celebrates its 10^(th) anniversary in the professional stage lighting market – a decade of development, innovation and customer trust.
Bradmax Media Player
BRADMAX is a company specializing in delivering video playback solutions acrossmultiple platforms. Their flagship product is a multi-platform HTML5 video player thatsupports a wide range of video formats such as DASH, HLS, and SmoothStreaming,while providing adaptive bitrate streaming, DRM support (Google Widevine, AppleFairPlay, Microsoft PlayReady), and advanced analytics options. The Bradmax player isused on websites, mobile applications, Smart TVs, and OTT applications.Bradmax also offers consulting services, helping clients solve video playback issuesacross various platforms. These services include integration with external systems,performance optimization, troubleshooting playback on older devices, and DRMsupport. The company operates internationally, serving clients in over 40 countries with morethan 20 years of industry experience.